Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lymphocyte response to phytohemagglutinin in Hodgkin's disease.

× No keyword cloud information.

28 in total

1. B and T lymphocytes in Hodgkin's disease. Analysis at diagnosis and following therapy.

Authors: K J Gajl-Peczalska; C D Bloomfield; H Sosin; J H Kersey
Journal: Clin Exp Immunol Date: 1976-01 Impact factor: 4.330

2. Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes.

Authors: W J Catalona; J L Tarpley; C Potvin; P B Chretien
Journal: Clin Exp Immunol Date: 1975-02 Impact factor: 4.330

3. Mixed lymphocyte culture stimulatory and responding capacity of lymphocytes from patients with lymphoproliferative diseases.

Authors: H Rühl; W Vogt; G Bochert; S Schmidt; R Moelle; H Schaoua
Journal: Clin Exp Immunol Date: 1975-01 Impact factor: 4.330

4. Discordance of Epstein-Barr Virus (EBV) specific humoral and cellular immunity in patients with malignant lymphomas: elevated antibody titres and lowered in vitro lymphocyte reactivity.

Authors: C H Ten Napel; T H The; J Van Egten-Bijker; G C de Gast; M R Halie; M M Langenhuysen
Journal: Clin Exp Immunol Date: 1978-12 Impact factor: 4.330

5. [Immunologic status in Hodgkin patients: correlation with Epstein-Barr virus titers].

Authors: V Diehl; K Hegge; J Kalden; U Desselberger; P Krull
Journal: Blut Date: 1976-04

6. Ferritin on the surface of lymphocytes in Hodgkin's disease patients. A possible blocking substance removed by levamisole.

Authors: C Moroz; N Lahat; M Biniaminov; B Ramot
Journal: Clin Exp Immunol Date: 1977-07 Impact factor: 4.330

Lymphocyte response to phytohemagglutinin in Hodgkin's disease.

1. B and T lymphocytes in Hodgkin's disease. Analysis at diagnosis and following therapy.

2. Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes.

3. Mixed lymphocyte culture stimulatory and responding capacity of lymphocytes from patients with lymphoproliferative diseases.

4. Discordance of Epstein-Barr Virus (EBV) specific humoral and cellular immunity in patients with malignant lymphomas: elevated antibody titres and lowered in vitro lymphocyte reactivity.

5. [Immunologic status in Hodgkin patients: correlation with Epstein-Barr virus titers].

6. Ferritin on the surface of lymphocytes in Hodgkin's disease patients. A possible blocking substance removed by levamisole.

7. Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease.

8. Immune function of successfully treated lymphoma patients.

9. [Hodgkin's disease: effect of spenectomy on the immune status (author's transl)].

10. Assessment of host defence against infection during chemotherapy of Hodgkin's disease.